GYRE THERAPEUTICS, INC. (GYRE)
1 Item 5.02 filing since 2026-10-22 · roles: CEO. Nasdaq. Pharmaceutical Preparations. State: CA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-10-22 | Compensation only | CEO | subscribers | — | GYRE THERAPEUTICS, INC. (GYRE): CEO Ying Luo, Ph.D. compensation terms |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works